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A corrigendum on
Bacteriophage Procurement for Therapeutic Purposes
by Weber-Da˛browska, B., Jon´czyk-Matysiak, E., Z˙aczek, M., Łobocka, M. B., Łusiak-Szelachowska,
M., and Górski, A. (2016). Front. Microbiol. 7:1177. doi: 10.3389/fmicb.2016.01177
In the original article, we neglected to include the Wrocław Centre of Biotechnology as a funding
source. The full Funding statement should read as follows:
This work was financially supported by the project “Innovative Bacteriophage Preparation for
the Treatment of Diabetic Foot” no. POIG.01.03.01-02-048/12 funded by the National Center
for Research and Development. MŁ contribution was financially supported by the statutory funds
for the Institute of Biochemistry and Biophysics, PAS. Publication was also supported by Wrocław
Centre of Biotechnology, programme, the Leading National Research Centre (KNOW) for years
2014–2018.
The authors apologize for this oversight. This error does not change the scientific conclusions of
the article in any way.
Conflict of Interest Statement: BW-D and AG are inventors of a patent (EP1 406 642 B1, PL 19543781, US 7, 232564 B2)
for procedure of preparing phages against S. aureus and P. aeruginosa (P382800; US 20100227376 A1) and a method of
obtaining bacteriophage preparations containing trace amounts of endotoxins owned by the Institute of Immunology and
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